Skip to content

API PHARMA: what changed

BE 0805.949.739NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€33,164
2024 · €34,976-€1,812
Equity
€69,569
2024 · €37,239+€32,331
Cash
€90,141
2024 · €46,660+€43,480
Balance sheet total
€116,460
2024 · €81,294+€35,165

Largest movements

2024 to 2025
Assets
  • Cash +€43,480

    up €43,480 (+93.2%), from €46,660 to €90,141

    mainly Net result for the year (+€33,164) and Tax, wage and social debts (+€10,054)

  • Tangible fixed assets -€8,652

    down €8,652 (-36.5%), from €23,689 to €15,037

Equity and liabilities
  • Profit (loss) carried forward +€32,331

    up €32,331 (+91.7%), from €35,239 to €67,569

  • Tax, wage and social debts +€10,054

    up €10,054 (+57.3%), from €17,551 to €27,605

    of which Taxes: +€10,054

  • Debts after one year -€6,750

    down €6,750 (-59.2%), from €11,397 to €4,648

  • Trade debts -€1,269

    down €1,269 (-72.0%), from €1,761 to €493

Income statement
  • Depreciation +€6,382

    up €6,382 (+281%), from €2,269 to €8,652

  • Gross operating margin +€2,556

    up €2,556 (+5.1%), from €50,122 to €52,678

  • Other operating charges -€2,360

    down €2,360 (-86.6%), from €2,726 to €365

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €34,976
Gross operating margin +€2,556
Depreciation -€6,382
Other operating charges +€2,360
Financial charges -€431
Taxes +€85
Result 2025 €33,164
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€50,807
Investment €0
Financing -€7,326
Cash 2024 €46,660
Net result for the year +€33,164
Depreciation +€8,652
Receivables within one year -€47
Deferred charges and accrued income -€290
Trade debts -€1,269
Tax, wage and social debts +€10,054
Other debts +€543
Debts after one year -€6,750
Current portion of long-term debt +€256
Contributions, distributions and other -€833
Cash 2025 €90,141
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €81,294 €116,460 +€35,165 +43.3%
Fixed assets 21/28 €23,689 €15,037 -€8,652 -36.5%
Tangible fixed assets 22/27 €23,689 €15,037 -€8,652 -36.5%
Furniture and vehicles 24 €23,689 €15,037 -€8,652 -36.5%
Current assets 29/58 €57,606 €101,423 +€43,817 +76.1%
Amounts receivable within one year 40/41 €10,945 €10,992 +€47 +0.4%
Trade receivables 40 €10,945 €10,992 +€47 +0.4%
Cash at bank and in hand 54/58 €46,660 €90,141 +€43,480 +93.2%
Deferred charges and accrued income 490/1 - €290 +€290
Total equity and liabilities 10/49 €81,294 €116,460 +€35,165 +43.3%
Equity 10/15 €37,239 €69,569 +€32,331 +86.8%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €35,239 €67,569 +€32,331 +91.7%
Amounts payable 17/49 €44,056 €46,890 +€2,835 +6.4%
Amounts payable after more than one year 17 €11,397 €4,648 -€6,750 -59.2%
Financial debts 170/4 €11,397 €4,648 -€6,750 -59.2%
Amounts payable within one year 42/48 €32,658 €42,243 +€9,585 +29.3%
Current portion of amounts payable after more than one year 42 €6,493 €6,750 +€256 +3.9%
Trade debts 44 €1,761 €493 -€1,269 -72.0%
Suppliers 440/4 €1,761 €493 -€1,269 -72.0%
Taxes, remuneration and social security 45 €17,551 €27,605 +€10,054 +57.3%
Taxes 450/3 €15,951 €26,005 +€10,054 +63.0%
Remuneration and social security 454/9 €1,600 €1,600 = 0.0%
Other amounts payable 47/48 €6,852 €7,395 +€543 +7.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,269 €8,652 +€6,382 +281%
Other operating charges 640/8 €2,726 €365 -€2,360 -86.6%
Gross operating margin 9900 €50,122 €52,678 +€2,556 +5.1%
Operating profit (loss) 9901 €45,127 €43,660 -€1,466 -3.2%
Financial charges 65/66B €278 €709 +€431 +155%
Recurring financial charges 65 €278 €709 +€431 +155%
Profit (loss) for the period before taxes 9903 €44,849 €42,951 -€1,897 -4.2%
Income taxes 67/77 €9,873 €9,788 -€85 -0.9%
Profit (loss) for the period 9904 €34,976 €33,164 -€1,812 -5.2%
Profit (loss) for the period to be appropriated 9905 €34,976 €33,164 -€1,812 -5.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€118,231 to €151,610

Midpoint €132,139 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €69,569
Capitalised earnings €166,893 to €233,650
Indication €118,231 to €151,610

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€69,569
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€69,569

Capitalised earnings

net result for the year (9904)
2025
€33,164
2024
€34,976
2023
€1,955
Average result
€23,365
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€166,893 / €194,708 / €233,650

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.